Oxidative stress and hypertension

Journal of the American Society of Hypertension

Volumn 1, Issue 1, 2007, Pages 30-44

  Harrison, David G ^a   Gongora, Maria Carolina ^a   Guzik, Tomasz J ^a   Widder, Julian ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

multidrug resistance protein 1; NADPH oxidase; nitric oxide; Nox enzymes; superoxide; tetrahydrobiopterin

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN II; ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE; MULTIDRUG RESISTANCE PROTEIN 1; NITRIC OXIDE SYNTHASE; PROTEIN P22; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; TETRAHYDROBIOPTERIN; VERLUKAST; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL FUNCTION; BRAIN; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG TREATMENT FAILURE; ENZYME ACTIVITY; HEART FAILURE; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; KIDNEY; LOW DRUG DOSE; MAMMAL CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNTHESIS; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 34247877763     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2006.11.006     Document Type: Article

References (76)

1. Harrison D.G., and Dikalov S. Oxidative events in cell and vascular biology. In: Re R., DiPette D., Schiffrin E., and Sowers J. (Eds). Molecular mechanisms in hypertension. 1st ed. (2005), Taylor & Francis Medical Books, Abingdon, UK
2. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
3. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24 (2003) 471-478
4. Huie R.E., and Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 18 (1993) 195-199
5. Afanas Ev I.B. Superoxide ion chemistry and biological implications. 1st ed. (1989), CRC Press, Boca Raton, FL
6. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., and Inoue M. Does superoxide underlie the pathogenesis of hypertension?. Proc Natl Acad Sci U S A 88 (1991) 10045-10048
7. Fukui T., Ishizaka N., Rajagopalan S., et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80 (1997) 45-51
8. Landmesser U., Cai H., Dikalov S., et al. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40 (2002) 511-515
9. Landmesser U., Dikalov S., Price S.R., et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111 (2003) 1201-1209
10. Laursen J.B., Rajagopalan S., Galis Z., Tarpey M., Freeman B.A., and Harrison D.G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95 (1997) 588-593
11. Schnackenberg C.G., Welch W.J., and Wilcox C.S. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32 (1998) 59-64
12. Schnackenberg C.G., and Wilcox C.S. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 33 (1999) 424-428
13. Hasdan G., Benchetrit S., Rashid G., Green J., Bernheim J., and Rathaus M. Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int 61 (2002) 586-590
14. Mueller C.F., Laude K., McNally J.S., and Harrison D.G. ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 25 (2005) 274-278
15. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285 (2003) R277-R297
16. Gorlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87 (2000) 26-32
17. Jones S.A., O'Donnell V.B., Wood J.D., Broughton J.P., Hughes E.J., and Jones O.T. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 271 (1996) H1626-H1634
18. Touyz R.M., Chen X., Tabet F., et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90 (2002) 1205-1213
19. Wang H.D., Pagano P.J., Du Y., et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 82 (1998) 810-818
20. Ago T., Kitazono T., Ooboshi H., et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109 (2004) 227-233
21. Hilenski L.L., Clempus R.E., Quinn M.T., Lambeth J.D., and Griendling K.K. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24 (2004) 677-683
22. Banfi B., Tirone F., Durussel I., et al. Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5). J Biol Chem 279 (2004) 18583-18591
23. Banfi B., Molnar G., Maturana A., et al. A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem 276 (2001) 37594-37601
24. Groemping Y., and Rittinger K. Activation and assembly of the NADPH oxidase: a structural perspective. Biochem J 386 (2005) 401-416
25. Banfi B., Clark R.A., Steger K., and Krause K.H. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 278 (2003) 3510-3513
26. Ambasta R.K., Kumar P., Griendling K.K., Schmidt H.H., Busse R., and Brandes R.P. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279 (2004) 45935-45941
27. Miriyala S., Gongora Nieto M.C., Mingone C., et al. Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 113 (2006) 2818-2825
28. Beswick R.A., Dorrance A.M., Leite R., and Webb R.C. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38 (2001) 1107-1111
29. Hu L., Zhang Y., Lim P.S., et al. Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 19 (2006) 413-418
30. Zhang Y., Chan M.M., Andrews M.C., et al. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am J Hypertens 18 (2005) 910-916
31. Modlinger P., Chabrashvili T., Gill P.S., et al. RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension 47 (2006) 238-244
32. Matsuno K., Yamada H., Iwata K., et al. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 (2005) 2677-2685
33. Kawczynska-Drozdz A., Olszanecki R., Jawien J., et al. Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats. Am J Hypertens 19 (2006) 764-767
34. Weber D.S., Rocic P., Mellis A.M., et al. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol 288 (2005) 37-42
35. Chabrashvili T., Tojo A., Onozato M.L., et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39 (2002) 269-274
36. Wilcox C.S. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?. Am J Physiol Regul Integr Comp Physiol 289 (2005) R913-R935
37. Wilcox C.S. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand 179 (2003) 217-223
38. Klahr S. Oxygen radicals and renal diseases. Miner Electrolyte Metab 23 (1997) 140-143
39. Tian N., Thrasher K.D., Gundy P.D., Hughson M.D., and Manning Jr. R.D. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 45 (2005) 934-939
40. Chade A.R., Rodriguez-Porcel M., Herrmann J., et al. Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol 15 (2004) 958-966
41. Koya D., Hayashi K., Kitada M., Kashiwagi A., Kikkawa R., and Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14 8 suppl 3 (2003) S250-S253
42. Meng S., Cason G.W., Gannon A.W., Racusen L.C., and Manning Jr. R.D. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41 (2003) 1346-1352
43. Quiroz Y., Bravo J., Herrera-Acosta J., Johnson R.J., and Rodriguez-Iturbe B. Apoptosis and NFkappaB activation are simultaneously induced in renal tubulointerstitium in experimental hypertension. Kidney Int Suppl 86 (2003) S27-S32
44. Zimmerman M.C., Lazartigues E., Lang J.A., et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91 (2002) 1038-1045
45. Zimmerman M.C., Dunlay R.P., Lazartigues E., et al. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 95 (2004) 532-539
46. Erdos B., Broxson C.S., King M.A., Scarpace P.J., and Tumer N. Acute pressor effect of central angiotensin II is mediated by NAD(P)H-oxidase-dependent production of superoxide in the hypothalamic cardiovascular regulatory nuclei. J Hypertens 24 (2006) 109-116
47. Li Z., Mao H.Z., Abboud F.M., and Chapleau M.W. Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ Res 79 (1996) 802-811
48. Duffy S.J., Gokce N., Holbrook M., et al. Treatment of hypertension with ascorbic acid. Lancet 354 (1999) 2048-2049
49. Czernichow S., Blacher J., and Hercberg S. Antioxidant vitamins and blood pressure. Curr Hypertens Rep 6 (2004) 27-30
50. Czernichow S., Bertrais S., Blacher J., et al. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI. MAX study: association with plasma antioxidant levels. J Hypertens 23 (2005) 2013-2018
51. Lonn E., Bosch J., Yusuf S., et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293 (2005) 1338-1347
52. Guzik T.J., and Harrison D.G. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today 11 (2006) 524-533
53. Cadenas E., Wefers H., Muller A., Brigelius R., and Sies H. Active oxygen metabolites and their action in the hepatocyte. Studies on chemiluminescence responses and alkane production. Agents Actions Suppl 11 (1982) 203-216
54. Halvey P.J., Watson W.H., Hansen J.M., Go Y.M., Samali A., and Jones D.P. Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signalling. Biochem J 386 (2005) 215-219
55. Gongora M, Qin Z, Laude K, et al. The role of extracellular superoxide dismutase in hypertension. Hypertension In press.
56. Hink U., Li H., Mollnau H., et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88 (2001) E14-E22
57. Uemura S., Matsushita H., Li W., et al. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 88 (2001) 1291-1298
58. Benecke R., Strumper P., and Weiss H. Electron transfer complex I defect in idiopathic dystonia. Ann Neurol 32 (1992) 683-686
59. Seppet E., Eimre M., Peet N., et al. Compartmentation of energy metabolism in atrial myocardium of patients undergoing cardiac surgery. Mol Cell Biochem 270 (2005) 49-61
60. Sayen M.R., Gustafsson A.B., Sussman M.A., Molkentin J.D., and Gottlieb R.A. Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production. Am J Physiol Cell Physiol 284 (2003) C562-C570
61. Waypa G.B., Chandel N.S., and Schumacker P.T. Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res 88 (2001) 1259-1266
62. Deshpande S.S., Angkeow P., Huang J., Ozaki M., and Irani K. Rac1 inhibits TNF-alpha-induced endothelial cell apoptosis: dual regulation by reactive oxygen species. FASEB J 14 (2000) 1705-1714
63. Sato W., Tanaka M., Sugiyama S., et al. Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Am Heart J 128 (1994) 733-741
64. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100 (1997) 2153-2157
65. Stuehr D.J. Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol 37 (1997) 339-359
66. Wang J., Stuehr D.J., and Rousseau D.L. Tetrahydrobiopterin-deficient nitric oxide synthase has a modified heme environment and forms a cytochrome P-420 analogue. Biochemistry 34 (1995) 7080-7087
67. Michel T., and Feron O. Nitric oxide synthases: which, where, how, and why?. J Clin Invest 100 (1997) 2146-2152
68. Guzik T.J., Mussa S., Gastaldi D., et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105 (2002) 1656-1662
69. Guzik T.J., Sadowski J., Guzik B., et al. Coronary artery superoxide production and Nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 26 (2006) 333-339
70. Kuzkaya N., Weissmann N., Harrison D.G., and Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278 (2003) 22546-22554
71. Laursen J.B., Somers M., Kurz S., et al. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103 (2001) 1282-1288
72. Andreoli S.P., Mallett C.P., and Bergstein J.M. Role of glutathione in protecting endothelial cells against hydrogen peroxide oxidant injury. J Lab Clin Med 108 (1986) 190-198
73. Dickinson D., and Forman H. Glutathione in defense and signaling: lessons from a small thiol. Ann N Y Acad Sci 973 (2002) 488-504
74. Harlan J.M., Levine J.D., Callahan K.S., Schwartz B.R., and Harker L.A. Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. J Clin Invest 73 (1984) 706-713
75. Mueller C.F., Widder J.D., McNally J.S., McCann L., Jones D.P., and Harrison D.G. The role of the multidrug resistance protein-1 in modulation of endothelial cell oxidative stress. Circ Res 97 (2005) 637-644
76. Wijnholds J., Evers R., van Leusden M.R., et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 3 (1997) 1275-1279